Go to deals
Private Equity | Business Support Services | TMT

CDP Equity was assisted in the fairness opinion on the merger og Nexi–SIA nets

The shareholders of SIA S.p.A.–CDP Equity have conducted a fairness opinion on the merger of Nexi–SIA nets.

SIA is a European leader in the design, construction and management of infrastructures and technological services dedicated to financial institutions, central banks, companies and public administrations, in the card and merchant solutions, digital payment, and capital market and network solutions.

Nexi is an Italian company listed on the MTA market of the Italian Stock Exchange. It is the leading PayTech company in Italy, which operates in consolidated partnerships with approximately 150 banking institutions. Nexi operates in three market segments: merchant services and solutions, cards and digital payments, and digital banking solutions.

Oaklins’ team in Italy assisted CDP Equity as financial advisor in the transaction, drafting the fairness opinion on the Nexi–SIA exchange ratio established by the agreement.

Service
Corporate finance services
Parties

Talk to the deal team

 Goffredo  Frisina

Goffredo Frisina

Managing Director
Milan, Italy
Oaklins Italy

Related deals

Confirma Software has acquired Quick Systems
Private Equity | TMT

Confirma Software has acquired Quick Systems

Quick Systems AS has become part of Confirma Software, backed by Abry Partners.

Learn more
PSG Equity has made a strategic growth investment in Rodeo Software
Private Equity | TMT

PSG Equity has made a strategic growth investment in Rodeo Software

PSG Equity has made a strategic growth investment in Rodeo Software B.V., the leading project management SaaS platform, to accelerate its growth through increased GTM investment and geographical expansion.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more